Y Intercept Hong Kong Ltd Makes New $546,000 Investment in SPDR S&P Biotech ETF $XBI

Y Intercept Hong Kong Ltd acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,586 shares of the exchange traded fund’s stock, valued at approximately $546,000.

A number of other hedge funds also recently bought and sold shares of the business. Goldman Sachs Group Inc. boosted its holdings in SPDR S&P Biotech ETF by 33.0% in the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after acquiring an additional 3,353,029 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of SPDR S&P Biotech ETF by 625.1% during the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after acquiring an additional 12,344,558 shares during the period. Bessemer Group Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 4.4% in the 2nd quarter. Bessemer Group Inc. now owns 1,494,666 shares of the exchange traded fund’s stock valued at $123,951,000 after purchasing an additional 62,600 shares during the period. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in SPDR S&P Biotech ETF in the first quarter worth $85,155,000. Finally, Hsbc Holdings PLC raised its holdings in SPDR S&P Biotech ETF by 2.7% in the first quarter. Hsbc Holdings PLC now owns 819,267 shares of the exchange traded fund’s stock worth $65,379,000 after purchasing an additional 21,804 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $109.29 on Friday. The stock has a market cap of $6.63 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $113.21. The firm has a 50-day moving average of $101.83 and a 200 day moving average of $90.10.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.